Thomas Hutson, DO, PharmD

Future Perspectives in Renal Cell Carcinoma (RCC)

June 29, 2022

Video

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

June 22, 2022

Video

Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.

Tivozanib: Adverse Event Profile and How Toxicities are Managed

June 22, 2022

Video

Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.

Clinical Implications of the TIVO-3 Trial

June 15, 2022

Video

Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.